Potential anti-diabetic applications of a new molecule with affinity for beta 3-adrenoceptors.


beta 3-adrenoceptors have been described through both molecular and pharmacological studies. In this context, it has been characterized the beta 3-adrenoceptor agonist activity of a new compound (Trecadrine), and evaluated whether it exhibits additional activity at beta 1- and beta 2-adrenoceptor subtypes. In addition, it has been tested its potential anti… (More)


  • Presentations referencing similar topics